Suppr超能文献

持续给予健康人和肌腺苷酸脱氨酶缺乏症患者D-核糖后的代谢情况。

Metabolism of D-ribose administered continuously to healthy persons and to patients with myoadenylate deaminase deficiency.

作者信息

Gross M, Reiter S, Zöllner N

机构信息

Medizinische Poliklinik, Universität München.

出版信息

Klin Wochenschr. 1989 Dec 4;67(23):1205-13. doi: 10.1007/BF01716208.

Abstract

D-ribose was administered orally or intravenously over at least 5 h to eight healthy volunteers and five patients with myoadenylate deaminase deficiency. Intravenous administration rates were 83, 167, and 222 mg/kg/h, which were well tolerated but oral administration of more than 200 mg/kg/h caused diarrhea. The average steady state serum ribose level ranged between 4.8 mg/100 ml (83 mg/kg/h, oral administration) and 81.7 mg/100 ml (222 mg/kg/h, intravenous administration). Serum glucose level decreased during ribose administration. The intestinal absorption rate of orally administered ribose was 87.8%-99.8% of the intake at doses up to 200 mg/kg/h without first pass effect. Urinary losses were 23% of the intravenously administered dose at 222 mg/kg/h. Ribose appeared to be excreted by glomerular filtration without active reabsorption; a renal threshold could not be demonstrated. The amount of ribose transported back from the tubular lumen depended on the serum ribose level. There was no difference in ribose turnover in healthy subjects and patients with MAD deficiency.

摘要

将D - 核糖经口服或静脉注射至少5小时给予8名健康志愿者和5名肌腺苷酸脱氨酶缺乏症患者。静脉注射速率分别为83、167和222毫克/千克/小时,耐受性良好,但口服超过200毫克/千克/小时会导致腹泻。平均稳态血清核糖水平在4.8毫克/100毫升(83毫克/千克/小时,口服)至81.7毫克/100毫升(222毫克/千克/小时,静脉注射)之间。在核糖给药期间血清葡萄糖水平下降。在剂量高达200毫克/千克/小时且无首过效应时,口服核糖的肠道吸收率为摄入量的87.8% - 99.8%。在222毫克/千克/小时时,尿中损失量为静脉注射剂量的23%。核糖似乎通过肾小球滤过排泄,无主动重吸收;未证明有肾阈。从肾小管腔运回的核糖量取决于血清核糖水平。健康受试者和肌腺苷酸脱氨酶缺乏症患者的核糖周转率无差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验